Patents Assigned to QIAGEN GmbH
  • Patent number: 10144952
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using butanamide.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: December 4, 2018
    Assignee: QIAGEN GmbH
    Inventors: Ralf Wyrich, Thorsten Voss, Daniel Grölz
  • Patent number: 10094749
    Abstract: The present invention refers to a device, comprising a hollow body having at least one open end and at least one barrier inside or at the end of the hollow body, which is non-permeable for liquids and solids under ambience conditions, however, becomes liquid-permeable by applying an external force like pressure, drag force or driving power to said barrier, the use of such a device for collection, storage, treatment or isolation of a biomolecule or biomolecules containing samples, a method for preparation of said device and a method for isolation or purification of any biomolecules using said device.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: October 9, 2018
    Assignee: QIAGEN GmbH
    Inventors: Margit Hiesinger, Vera Holländer, Markus Müller, Karin Schulte, Andre Schrader
  • Patent number: 10088469
    Abstract: A method for obtaining blood plasma from a whole blood sample comprising the following steps a) contacting the whole blood sample with a composition (A) comprising at least one carboxylic acid, wherein the addition of the acidic composition (A) and optionally further additives to the whole blood sample provides a sample mixture having a pH that lies in a range from 2.5 to 5; b) binding red and white blood cells to a magnetic solid phase; wherein step a) and step b) can be performed sequentially or simultaneously, c) separating the solid phase with the bound cells from the remaining sample thereby providing blood plasma.
    Type: Grant
    Filed: August 29, 2013
    Date of Patent: October 2, 2018
    Assignee: QIAGEN GmbH
    Inventors: Andy Wende, Sabine Werner, Ralf Himmelreich
  • Patent number: 10087482
    Abstract: The present invention relates to a reaction mixture for the amplification of nucleic acids, the non-methylated cytosine bases of which have been converted to uracil bases by means of a bisulfition reaction. The invention also discloses methods for amplifying bisulfited nucleic acid and for determining the nucleic acid methylation state, and also kits based on the reaction mixture according to the invention.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: October 2, 2018
    Assignee: QIAGEN GMBH
    Inventors: Christian Korfhage, Dirk Loeffert, Ralf Peist, Nicolas Rudinger
  • Patent number: 10081806
    Abstract: The present invention relates to a method for recovering an aqueous phase comprising biomolecules dissolved therein from a multiphasic mixture, comprising at least said aqueous phase and a further liquid phase which is immiscible with said aqueous phase wherein said further liquid phase comprises at least one hydrocarbon compound. The invention further relates to the use of a hydrophilic filtering material, a device comprising such a filtering material or a kit comprising said device for recovering an aqueous phase comprising biomolecules dissolved therein from a mixture of said aqueous phase and at least one hydrocarbon compound comprising further liquid phase which is immiscible with said aqueous phase.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: September 25, 2018
    Assignee: Qiagen GmbH
    Inventors: Jörg Hucklenbroich, Frank Narz
  • Patent number: 10011826
    Abstract: The present invention relates to a method of isolating/extracting in parallel various biomolecules, in particular nucleic acids and proteins, from the same fixed biological samples, to the quantification and analysis of the biomolecules isolated by the method of the invention, and to a kit for isolating/extracting in parallel various biomolecules from a fixed sample, to the use of said kit for diagnosing, prognosing, deciding the therapy of and monitoring the therapy of a disease.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: July 3, 2018
    Assignee: QIAGEN GmbH
    Inventors: Vera Holländer, Peter Porschewski
  • Patent number: 10011827
    Abstract: The method for isolating nucleic acids from a food sample comprising the following steps: a) obtaining a food enrichment culture; b) transferring a portion of the food enrichment culture into a reaction vessel thereby providing a food enrichment sample and providing a water-immiscible phase in contact with the food enrichment culture; c) lysing the food enrichment sample to provide a lysed sample; d) isolating nucleic acids from the lysed sample. Food enrichment culture samples are known to contain high concentrations of organic and/or liposoluble inhibitors. By contacting the enrichment culture sample with a water-immiscible phase before the actual DNA extraction procedure starts, part of the lipophilic inhibitors is expected to cross the phase interface due to an enhanced solubility in the organic phase and thereby become depleted.
    Type: Grant
    Filed: February 28, 2013
    Date of Patent: July 3, 2018
    Assignee: QIAGEN GmbH
    Inventors: Janina Cramer, Sarah Fakih, Corinna Küppers, Holger Engel
  • Patent number: 9994891
    Abstract: The present invention pertains inter alia to a method for analyzing a sample comprising biomolecules, which comprises the following steps: A a) lysing the sample to provide a lysed sample and optionally clearing the lysed sample; b) contacting at least a portion of the lysed sample with a dry composition comprising reagents for performing the analytical method, thereby providing a reconstituted composition; c) performing an analytical method using the reconstituted composition; or B a) contacting the sample with a lysis solution thereby providing a lysis mixture; b) using the lysis mixture to reconstitute a dry composition comprising reagents for performing the analytical method, thereby providing a reconstituted composition; c) performing an analytical method using the reconstituted composition, wherein the reconstituted composition is optionally cleared and wherein subsequent to step b) at least one step is performed which supports the lysis of the sample.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: June 12, 2018
    Assignee: QIAGEN GMBH
    Inventors: Andy Wende, Rainer Dahlke, Ralf Himmelreich, Thomas Rothmann, Michael Eberhard, Gerd Grosshauser, Markus Jeziorski, Hans Attig, Josef Drexler, Eva Holzer
  • Publication number: 20180142231
    Abstract: The present invention relates to a method for selectively depleting animal nucleic acids from non-animal nucleic acids in a sample, which comprises animal cells and at least one further type of cells, selected from microbial cells and plant cells or a combination thereof, to a lysis solution A to be used in and to a kit to carry out said method as well as to the use of a particular silica membrane as both, a filtration matrix for separating essentially intact microbial and/or plant cells from lysed animal cells and an adsorption matrix for nucleic acids, in particular in a method according to the present invention.
    Type: Application
    Filed: April 20, 2015
    Publication date: May 24, 2018
    Applicant: QIAGEN GmbH
    Inventors: Johann Kubicek, Thorsten Singer, Antje-Katrin Sander
  • Patent number: 9938520
    Abstract: The present invention provides a cost-efficient method for producing particles having a SiO2 containing surface wherein said method comprises a) providing an aqueous reaction composition comprising i) core particles, ii) an added base, iii) a silicate salt, and iv) a pH modulator wherein the pH value of the reaction composition is above the gelation pH value; b) agitating said reaction composition, wherein the pH modulator decreases the pH value of the reaction composition over time and wherein due to said decrease of the pH value of the reaction composition SiO2 is deposited onto the core particles, whereby particles are formed which have a diameter of 30 ?m or less; and c) obtaining the particles. Furthermore, silica particles having high nucleic acid binding properties are provided.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: April 10, 2018
    Assignee: QIAGEN GmbH
    Inventor: Roland Fabis
  • Patent number: 9914962
    Abstract: The present invention relates to a method for real-time monitoring and/or quantification of newly-synthesized complementary deoxyribonucleic acid (cDNA) during a reverse transcription reaction of an ribonucleic acid (RNA) template in a sample, the method using a fluorogenic dye binding to RNA:cDNA hybrids. The present invention also relates to the use of this method as well as to kits employing the fluorogenic dye.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: March 13, 2018
    Assignee: QIAGEN GMBH
    Inventor: Nan Fang
  • Patent number: 9914121
    Abstract: A tube for chemical, biological or biotechnological matter is provided, wherein the tube has a positioning element, the positioning element shaped for engagement in a corresponding structure provided in a carrier.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: March 13, 2018
    Assignee: QIAGEN GMBH
    Inventors: Sasa Lazevski, Thomas Voit
  • Patent number: 9901935
    Abstract: A gripper unit for handling a vessel for receiving biological material is proposed, inter alia. The vessel has a lid which can assume an open position and a closed position. The gripper unit comprises a gripper for gripping and releasing the vessel, and a lid holder, for holding a lid in a defined position in relation to the vessel. The defined position is an open position of the lid.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: February 27, 2018
    Assignee: QIAGEN GMBH
    Inventors: Andreas Schaefer, Thomas Voit, Walter Tschopp, Adrian Geiger, Markus Zbinden, Harald Hibbing, Andreas Karl, Frank Eigemeier, Volker Behrmann, Dietmar Kopp, Andreas Schmiede
  • Patent number: 9890413
    Abstract: The invention related to a method for the stabilization, purification or/and isolation of nucleic acids from material samples, in particular, stool samples, which can contain impurities and inhibitors or interfering substances. The invention further relates to a reagent kit for carrying out this method. The basis of the invention is, in particular, a method for purification, stabilization or/and isolation of nucleic acids from material samples, whereby a buffer is added to the sample containing the nucleic acids, with a pH value of 2 to 7, a salt concentration of at least 100 mM, or/and a phenol neutralizing substance. According to the invention, pure nucleic acids which may be amplified can be obtained from faecal samples by a simple method, which are suitable for diagnostic proof of infection, in particular, bacterial or viral infection, or mutation, in particular, for tumor-specific DNA mutations.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: February 13, 2018
    Assignee: QIAGEN GMBH
    Inventor: Markus Sprenger-Haussels
  • Patent number: 9849453
    Abstract: The present invention relates to improved methods for processing fluids and to a fluid processing device (1) for use in a centrifuge comprising: (a) a first holder (14) form-fit to the shape of a first tube (18) for holding said first tube (18) whereby said first tube (18) has a first cross section (A1); and (b) a second holder (22) form-fit to the shape of a second tube (26) for holding said second tube (26) whereby said second tube (26) has a second cross section (A2) that is different from said first cross section (A1). With the fluid processing devices and the methods according to the invention, it is possible to simplify the centrifugal processing steps for a given fluid processing sequence and to automate them.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: December 26, 2017
    Assignee: QIAGEN GMBH
    Inventors: Andreas Schaefer, Thomas Voit, Markus Zbinden, Andreas Schmiede
  • Patent number: 9822404
    Abstract: A method for determining whether a lysate contains sufficient biological sample material for a nucleic acid amplification reaction that includes preparing the lysate in the presence of at least one compound that inhibits the amplification reaction if insufficient biological sample material was present during preparation of the lysate, but does not inhibit the amplification reaction if sufficient biological sample material was present during preparation of the lysate, subjecting the lysate to the amplification reaction, and analyzing a result of the amplification reaction. Due to the presence of the compound in the amplification reaction, no amplification signal is obtained if insufficient biological sample material was present during preparation of the lysate but an amplification signal is obtained if sufficient biological sample material was present during preparation of the lysate.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: November 21, 2017
    Assignee: Qiagen GmbH
    Inventors: Gerd Grosshauser, Andy Wende, Ralf Himmelreich
  • Patent number: 9809612
    Abstract: The invention relates to a method and kits for isolating and/or purifying nucleic acids, in particular, short-chain nucleic acids, from a nucleic acid containing starting material, characterized by the following method steps: (a) bonding the nucleic acids to a nucleic acid bonding support material, wherein the starting material is brought into contact with the nucleic acid bonding support material in the presence of at least one chaotropic compound and preferably isopropanol, wherein the isopropanol is present in a concentration of ?15% (v/v) and ?35% (v/v), (b) optional elution of the bonded nucleic acids from the nucleic acid bonding support material. Said method is particularly suitable for the purification of foetal DNA from maternal blood.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: November 7, 2017
    Assignee: QIAGEN GmbH
    Inventors: Christoph Ritt, Martin Horlitz, Markus Sprenger-Haussels
  • Patent number: 9790250
    Abstract: The invention relates to a method and kits for isolating and/or purifying nucleic acids, in particular, short-chain nucleic acids, from a nucleic acid containing starting material, characterized by the following method steps: (a) bonding the nucleic acids to a nucleic acid bonding support material, wherein the starting material is brought into contact with the nucleic acid bonding support material in the presence of at least one chaotropic compound and preferably isopropanol, wherein the isopropanol is present in a concentration of ?25% (v/v) and ?35% (v/v), (b) optional elution of the bonded nucleic acids from the nucleic acid bonding support material. Said method is particularly suitable for the purification of foetal DNA from maternal blood.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: October 17, 2017
    Assignee: QIAGEN GmbH
    Inventors: Christoph Ritt, Martin Horlitz, Markus Sprenger-Haussels
  • Patent number: 9758812
    Abstract: The present invention is in the fields of molecular biology. The present invention is directed to novel compositions, methods and kits useful for the generation of nucleic acids from an RNA template and further nucleic acid replication. Specifically, the invention is directed to the generation and amplification of nucleic acids by reverse transcriptase-polymerase chain reaction.
    Type: Grant
    Filed: August 13, 2012
    Date of Patent: September 12, 2017
    Assignee: Qiagen GmbH
    Inventors: Nan Fang, Andreas Missel
  • Patent number: 9739704
    Abstract: Fluid processing tube for use in optical analysis comprising at least one first portion being made from a first material suitable for optical analysis and being configured to include two optical paths of different lengths, and at least one second portion connected to said first portion and being made from a second material different from said first material.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: August 22, 2017
    Assignee: QIAGEN GMBH
    Inventors: Thomas Voit, Michael Geissler, Harald Quintel, Roman Gruler